Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8+ T cell effector functions.

This study screened a library of gut microbiota-derived metabolites and identified DCA as a negative regulator for CD8+ T cell effector function and demonstrated causation between microbial DCA metabolism and anti-tumor CD8+ T cell response in CRC, suggesting potential directions for anti-tumor therapy.